World's Best Scientists 2026 revealed!
Klaus F. Rabe

Klaus F. Rabe

D-Index & Metrics

Medicine

D-Index
133
Citations
92280
World Ranking
2180
National Ranking
105

Klaus F. Rabe publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Klaus F. Rabe sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 820 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Klaus F. Rabe D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Klaus F. Rabe sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 133 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Klaus F. Rabe is affiliated with Kiel University in Germany. Their research primarily focuses on pulmonary and respiratory medicine, with significant contributions in subfields including physiology, immunology, immunology and allergy, and surgery. The scope of their work encompasses various aspects of respiratory diseases, mechanisms of respiratory support, and related immunological pathways.

Their main research topics include:

  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory Support and Mechanisms
  • Respiratory and Cough-Related Research
  • IL-33, ST2, and ILC Pathways
  • Allergic Rhinitis and Sensitization
  • Inhalation and Respiratory Drug Delivery

Among the recent papers published by Klaus F. Rabe are:

  • "Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD," 2020, New England Journal of Medicine

Frequent co-authors collaborating with Klaus F. Rabe include:

  • Thomas Bahmer
  • Erika von Mutius
  • Alberto Papi
  • Gesine Hansen
  • Dave Singh

The most common publication venues for Klaus F. Rabe's work are:

  • Pneumologie
  • American Journal of Respiratory and Critical Care Medicine
  • European Respiratory Journal
  • Klinische Pädiatrie
  • The Lancet Respiratory Medicine

Klaus F. Rabe has contributed to a substantial number of studies within the field of medicine, with a total of over 460 publications. Their research addresses important clinical and physiological aspects of respiratory diseases and has appeared frequently in high-impact journals related to respiratory medicine.

Best Publications

  • Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

    J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly

  • Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

    J. Bousquet;N. Khaltaev;A. A. Cruz;J. Denburg

  • Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

    Mario Castro;Jonathan Corren;Ian D. Pavord;Jorge Maspero

  • Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study

    KF Rabe;PA Vermeire;JB Soriano;WC Maier

  • Chronic obstructive pulmonary disease phenotypes: the future of COPD.

    Mei Lan K. Han;Alvar Agusti;Peter M. Calverley;Bartolome R. Celli

  • Burden and clinical features of chronic obstructive pulmonary disease (COPD).

    Romain A Pauwels;Klaus F Rabe

  • WORLDWIDE SEVERITY AND CONTROL OF ASTHMA IN CHILDREN AND ADULTS : THE GLOBAL ASTHMA INSIGHTS AND REALITY SURVEYS

    Klaus F Rabe;Mitsuru Adachi;Christopher K.W Lai;Joan B Soriano

  • Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.

    Klaus F. Rabe;Parameswaran Nair;Guy Brusselle;Jorge F. Maspero

  • Outcomes for COPD pharmacological trials: From lung function to biomarkers

    M. Cazzola;W. MacNee;F.J. Martinez;K.F. Rabe

  • Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

    Peter M A Calverley;Klaus F Rabe;Udo-Michael Goehring;Søren Kristiansen

  • Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.

    Parameswaran Nair;Sally Wenzel;Klaus F. Rabe;Arnaud Bourdin

  • Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma

    Jean Bousquet;Jean Bousquet;Eva Mantzouranis;Alvaro A. Cruz;Nadia Aït-Khaled

  • Complex chronic comorbidities of COPD

    L M Fabbri;F Luppi;B Beghé;K F Rabe

  • Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD

    Claus Vogelmeier;Bettina Hederer;Thomas Glaab;Hendrik Schmidt

  • From COPD to chronic systemic inflammatory syndrome

    Leonardo M Fabbri;Klaus F Rabe

  • Management of non-small-cell lung cancer: recent developments.

    Martin Reck;David F. Heigener;Tony Mok;Jean Charles Soria

  • Precision Diagnosis and Treatment for Advanced Non–Small-Cell Lung Cancer

    Martin Reck;Klaus F Rabe

  • Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

    Leonardo M Fabbri;Peter M A Calverley;José Luis Izquierdo-Alonso;Daniela S Bundschuh

  • Mediastinoscopy vs Endosonography for Mediastinal Nodal Staging of Lung Cancer: A Randomized Trial

    Jouke T. Annema;Jan P. van Meerbeeck;Robert C. Rintoul;Christophe Dooms

  • The Asthma-COPD Overlap Syndrome

    Dirkje S. Postma;Klaus F. Rabe

Frequent Co-Authors

Leonardo M. Fabbri
Leonardo M. Fabbri University of Ferrara
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School
Pieter S. Hiemstra
Pieter S. Hiemstra Leiden University Medical Center
Bartolome R. Celli
Bartolome R. Celli Brigham and Women's Hospital
Claus Vogelmeier
Claus Vogelmeier Philipp University of Marburg
Robert A. Stockley
Robert A. Stockley University of Birmingham
Stephen I. Rennard
Stephen I. Rennard University of Nebraska Medical Center
Peter M.A. Calverley
Peter M.A. Calverley University of Liverpool
Peter J. Sterk
Peter J. Sterk University of Amsterdam
Jadwiga A. Wedzicha
Jadwiga A. Wedzicha Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA isn’t limited to becoming a physician. Healthcare offers diverse online degrees and specialties that can expand your options or enhance your medical career. For example, there are affordable mha online programs for those interested in healthcare leadership and administration.

Advanced practice nurses can explore some of the best dnp programs online to step into clinical leadership or specialist roles. For those passionate about pharmacy, several accredited online pharmd programs allow working professionals to advance as doctors of pharmacy without relocating.

Technology-minded students may consider him programs to build a career in health information management—a rapidly growing field integrating health care and data management. Each path offers unique opportunities, often with flexible online formats, making it easier to balance education with work or family.

Best Scientists Citing Klaus F. Rabe

Trending Scientists

Recently Published Articles